CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,854 | $104.26 | $298K | 1,596,352 |
| 2023-12-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −4,541 | $105.06 | $477K | 1,591,811 |
| 2023-12-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −17,505 | $106.04 | $1.9M | 1,574,306 |
| 2023-12-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −100 | $107.66 | $11K | 1,574,206 |
| 2023-12-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −4,400 | $104.41 | $459K | 1,654,938 |
| 2023-12-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −6,263 | $105.50 | $661K | 1,648,675 |
| 2023-12-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −14,237 | $106.11 | $1.5M | 1,634,438 |
| 2023-12-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −100 | $107.66 | $11K | 1,634,338 |
| 2023-12-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −4,400 | $104.41 | $459K | 1,654,938 |
| 2023-12-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −6,263 | $105.50 | $661K | 1,648,675 |
| 2023-12-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −14,237 | $106.11 | $1.5M | 1,634,438 |
| 2023-12-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −100 | $107.66 | $11K | 1,634,338 |
| 2023-12-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,854 | $104.26 | $298K | 1,596,352 |
| 2023-12-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −4,541 | $105.06 | $477K | 1,591,811 |
| 2023-12-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −17,505 | $106.04 | $1.9M | 1,574,306 |
| 2023-12-11 | Krishnan Krish S President and CEO | Sale 10b5-1 | −100 | $107.66 | $11K | 1,574,206 |
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −5,007 | $125.23 | $627K | 1,619,199 |
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −5,452 | $126.17 | $688K | 1,613,747 |
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,874 | $127.18 | $238K | 1,611,873 |
| 2023-09-11 | Krishnan Suma President, R&D | Sale 10b5-1 | −10,557 | $128.37 | $1.4M | 1,601,316 |
Page 27 of 42 · 828 trades